AAAAAA

   
Results: 1-8 |
Results: 8
NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/
Authors: BROMIDGE SM DABBS S DAVIES DT DUCKWORTH DM FORBES IT HAM P JONES GE KING FD SAUNDERS DV STARR S THEWLIS KM WYMAN PA BLANEY FE NAYLOR CB BAILEY F BLACKBURN TP HOLLAND V KENNETT GA RILEY GJ WOOD MD
Citation: Sm. Bromidge et al., NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/, Journal of medicinal chemistry, 41(10), 1998, pp. 1598-1612
SB-242084, A SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST
Authors: KENNETT GA WOOD MD BRIGHT F TRAIL B RILEY G HOLLAND V AVENELL KY STEAN T UPTON N BROMIDGE S FORBES IT BROWN AM MIDDLEMISS DN BLACKBURN TP
Citation: Ga. Kennett et al., SB-242084, A SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST, Neuropharmacology, 36(4-5), 1997, pp. 609-620
PREVALENCE OF ANTIBODIES TO HEPATITIS-B AND HEPATITIS-C AMONG FIRE DEPARTMENT PERSONNEL PRIOR TO IMPLEMENTATION OF A HEPATITIS-B VACCINATION PROGRAM
Authors: PORTER ES MCDIARMID M MONTOPOLI M PRESSON A HOLLAND V
Citation: Es. Porter et al., PREVALENCE OF ANTIBODIES TO HEPATITIS-B AND HEPATITIS-C AMONG FIRE DEPARTMENT PERSONNEL PRIOR TO IMPLEMENTATION OF A HEPATITIS-B VACCINATION PROGRAM, Journal of occupational and environmental medicine, 38(2), 1996, pp. 125-127
M-CHLOROPHENYLPIPERAZINE (MCPP) IS AN ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR
Authors: THOMAS DR GAGER TL HOLLAND V BROWN AM WOOD MD
Citation: Dr. Thomas et al., M-CHLOROPHENYLPIPERAZINE (MCPP) IS AN ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR, NeuroReport, 7(9), 1996, pp. 1457-1460
HEPATITIS-B VACCINE FOR MEDICAL-STUDENTS
Authors: WALLIN MT MCDIARMID M MONTOPOLI M PRESSON A HOLLAND V
Citation: Mt. Wallin et al., HEPATITIS-B VACCINE FOR MEDICAL-STUDENTS, JAMA, the journal of the American Medical Association, 275(6), 1996, pp. 444-444
THE NOVEL 5-HT2C 2B RECEPTOR ANTAGONIST SB206553 IS A POTENT AND SURMOUNTABLE ANTAGONIST AT CLONED HUMAN RECEPTORS/
Authors: GAGER TL HOLLAND V THOMAS DR BLACKBURN TP
Citation: Tl. Gager et al., THE NOVEL 5-HT2C 2B RECEPTOR ANTAGONIST SB206553 IS A POTENT AND SURMOUNTABLE ANTAGONIST AT CLONED HUMAN RECEPTORS/, British Journal of Pharmacology, 117, 1996, pp. 133-133
SB 204741 IS A SELECTIVE ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR STABLY EXPRESSED IN HEK-293 CELLS
Authors: THOMAS DR BAXTER GS CAREY JE GAGER TL GALE DG HOLLAND V MUIR A WILSON S WOOD MD
Citation: Dr. Thomas et al., SB 204741 IS A SELECTIVE ANTAGONIST AT THE CLONED HUMAN 5-HT2B RECEPTOR STABLY EXPRESSED IN HEK-293 CELLS, British Journal of Pharmacology, 117, 1996, pp. 137-137
METHYL-5-INDOLYL)-N'-(3-METHYL-5-ISOTHIAZOLYL)UREA - A NOVEL, HIGH-AFFINITY 5-HT2B RECEPTOR ANTAGONIST
Authors: FORBES IT JONES GE MURPHY OE HOLLAND V BAXTER GS
Citation: It. Forbes et al., METHYL-5-INDOLYL)-N'-(3-METHYL-5-ISOTHIAZOLYL)UREA - A NOVEL, HIGH-AFFINITY 5-HT2B RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 38(6), 1995, pp. 855-857
Risultati: 1-8 |